Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients
Authors
Keywords
-
Journal
AIDS
Volume 25, Issue 18, Pages 2197-2208
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-10-05
DOI
10.1097/qad.0b013e32834bbb90
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B
- (2011) Vincent Soriano et al. AIDS
- IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
- (2011) Norma I Rallón et al. AIDS
- Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV–HCV-coinfected patients
- (2011) Ana Treviño et al. ANTIVIRAL THERAPY
- Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients
- (2011) Inmaculada Jiménez-Nácher et al. Expert Opinion on Drug Metabolism & Toxicology
- Distributive justice and the arrival of direct-acting antivirals: Who should be first in line?
- (2011) Andrew Aronsohn et al. HEPATOLOGY
- Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: Implications for treatment duration
- (2011) Jeremie Guedj et al. HEPATOLOGY
- Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
- (2011) Varun Garg et al. HEPATOLOGY
- Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients
- (2011) P Trimoulet et al. HIV MEDICINE
- Hepatitis C virus resistance to protease inhibitors
- (2011) Philippe Halfon et al. JOURNAL OF HEPATOLOGY
- Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C
- (2011) J. Nattermann et al. JOURNAL OF INFECTIOUS DISEASES
- Future hepatitis C virus treatment: interferon-sparing combinations
- (2011) Edward Gane LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
- (2010) Norma I Rallón et al. AIDS
- Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors
- (2010) A. Bae et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HIV Infection and the Liver: The Importance of HCV-HIV Coinfection and Drug-Induced Liver Injury
- (2010) Shehzad N. Merwat et al. Clinics in Liver Disease
- Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor
- (2010) A. Ghosal et al. DRUG METABOLISM AND DISPOSITION
- Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
- (2010) Patrick Marcellin et al. GASTROENTEROLOGY
- Clinical syndromes and consequences of antiretroviral-related hepatotoxicity
- (2010) Marina Núñez HEPATOLOGY
- New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals
- (2010) K. Seden et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Variability of the Polymerase Gene (NS5B) in Hepatitis C Virus-Infected Women
- (2010) J. T. Blackard et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
- (2010) Christian Markus Lange et al. JOURNAL OF HEPATOLOGY
- Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance
- (2010) F. Blanco et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients
- (2010) J. Medrano et al. JOURNAL OF VIRAL HEPATITIS
- Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
- (2010) Paul Y Kwo et al. LANCET
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
- (2010) L. Rong et al. Science Translational Medicine
- Antiretroviral drugs and liver injury
- (2009) Vincent Soriano et al. AIDS
- Viral hepatitis and HIV co-infection
- (2009) Vincent Soriano et al. ANTIVIRAL RESEARCH
- New Therapies for Hepatitis C Virus Infection
- (2009) Vincent Soriano et al. CLINICAL INFECTIOUS DISEASES
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C
- (2009) Salvatore Petta et al. HEPATOLOGY
- Detection of Hepatitis C Mutants With Natural Resistance to NS3/4A Protease Inhibitors in HIV/HCV-Coinfected Individuals Treated With Antiretroviral Therapy
- (2009) Giulia Morsica et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
- (2009) T. L. Kieffer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin
- (2008) Sonia Rodríguez-Nóvoa et al. AIDS
- Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy
- (2008) Silvana Gaudieri et al. HEPATOLOGY
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
- European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults
- (2008) JK Rockstroh et al. HIV MEDICINE
- Insulin Resistance Is Associated With Advanced Liver Fibrosis and High Body Mass Index in HIV/HCV-Coinfected Patients
- (2008) Pablo Ryan et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
- (2008) J. A. Mira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
- (2008) V. Soriano et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects
- (2008) Doug J. Bartels et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started